Institutional Ownership
Legend Biotech Corp
CUSIP 52490G102SPONSORED ADSLEGNQ1 2026
13D / 13G Filings
26
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
64.3%
Max % of class reported
Institutional Holders
187
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
26 filings · latest Feb 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2026 | Fmr LLC | 13G/A | 13.1% | 48.29M | SEC |
| 2 | Nov 5, 2025 | Fmr LLC | 13G/A | 15.0% | 55.09M | SEC |
| 3 | Aug 6, 2025 | Fmr LLC | 13G/A | 13.9% | 51.00M | SEC |
| 4 | Jun 6, 2025 | Fmr LLC | 13G/A | 10.9% | 40.16M | SEC |
| 5 | Feb 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 3.7% | 6.81M | SEC |
| 6 | Feb 12, 2025 | Fmr LLC | 13G/A | 7.3% | 26.61M | SEC |
| 7 | Nov 14, 2024 | Price T Rowe Associates Inc /Md/ | 13G/A | 6.1% | 11.14M | SEC |
| 8 | Nov 12, 2024 | Fmr LLC | 13G/A | 10.0% | — | SEC |
| 9 | Apr 5, 2024 | Blackrock Inc. | 13G/A | 3.0% | 10.77M | SEC |
| 10 | Feb 14, 2024 | Genscript Biotech Corp | 13G/A | 48.0% | 174.50M | SEC |
16 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Legend Biotech Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 25.70M | $464.85M |
| 2 | Deerfield Management Company, L.P. | 7.69M | $139.07M |
| 3 | Suvretta Capital Management, LLC | 7.58M | $137.14M |
| 4 | Hhlr Advisors, Ltd. | 5.98M | $108.26M |
| 5 | Westfield Capital Management Co LP | 5.76M | $104.26M |
| 6 | Blackrock, Inc. | 4.68M | $84.74M |
| 7 | Point72 Asset Management, L.P. | 3.89M | $70.30M |
| 8 | First Beijing Investment Ltd | 2.30M | $41.54M |
| 9 | Artisan Partners Limited Partnership | 2.25M | $40.78M |
| 10 | Two Sigma Investments, LP | 1.89M | $34.20M |